Mirvaso European Availability by March 2014

A Medscape article today announces that Mirvaso has been granted human approval and should be approved for sale across Europe by March 2014. The initial authorisation to market Mirvaso has been granted and are normally issued 67 days from the adoption of the `Summary of opinion’ Mirvaso Gains CHMP Support for Rosacea Erythema Treatment Miriam […]